Lundbeck
HLUN-B.CO
#2096
Rank
A$13.20 B
Marketcap
A$13.31
Share price
-2.27%
Change (1 day)
26.30%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Earnings for Lundbeck (HLUN-B.CO)

Earnings in 2026 (TTM): A$1.22 Billion

According to Lundbeck's latest financial reports the company's current earnings are A$4.03 Billion. In 2025 the company made an earning of A$1.13 Billion, an increase over its 2024 earnings that were of A$0.83 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lundbeck from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$1.22 B7.98%
2025 A$1.13 B36.57%
2024 A$0.83 B25.74%
2023 A$0.66 B21.77%
2022 A$0.54 B31.57%
2021 A$0.41 B-4.61%
2020 A$0.43 B-45.06%
2019 A$0.78 B-34.04%
2018 A$1.19 B12.83%
2017 A$1.05 B93.99%
2016 A$0.54 B-137.28%
2015 -A$1.47 Billion-1246.24%
2014 A$0.12 B-72.36%
2013 A$0.46 B4.38%
2012 A$0.44 B-55.18%
2011 A$0.98 B5.65%
2010 A$0.93 B-5.9%
2009 A$0.99 B